Abbott to separate into two leading companies
19 October 2011 | By Abbott
Abbott plans to separate into two companies, one in diversified medical products & the other in research-based pharmaceuticals...
List view / Grid view
News
Amgen appoints Anthony Hooper Executive Vice President Global Commercial Operations
19 October 2011 | By Amgen
Amgen appoints Anthony Hooper as Executive VP, Global Commercial Operations...
Bristol-Myers Squibb announces changes in senior management team
19 October 2011 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced a series of related changes within its Senior Management Team...
BYETTA® approved for use with insulin glargine in the U.S.
19 October 2011 | By Eli Lilly and Company
FDA has approved a new use for BYETTA® (exenatide) injection....
First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the risk of malaria by half in African children aged 5 to 17 months
18 October 2011 | By GlaxoSmithKline
RTS,S* reduces the risk of malaria by half...
AstraZeneca and Forest Laboratories to initiate phase III clinical trials for ceftazidime/avibactam
18 October 2011 | By AstraZeneca
ceftazidime/avibactam (CAZ-AVI) will enter phase III trials...
Novartis drug Gilenya® (fingolimod) shows up to 71% reduction in annualized relapse rates in MS patients
17 October 2011 | By Novartis
Novartis will showcase data from 13 abstracts on fingolimod (Gilenya®)...
Roche signs definitive agreement to acquire Anadys Pharmaceuticals
17 October 2011 | By Roche
Acquisition aims to expand future treatment options for hepatitis C patients...
ICON appoints Colin Stanley President of DOCS
17 October 2011 | By Weber Shandwick
ICON plc, announced the appointment of Colin Stanley as President of DOCS, the company’s global resourcing division...
Positive study of Herceptin given by subcutaneous injection
17 October 2011 | By Roche
Phase III study of a quicker route of administration shows comparable results to intravenous Herceptin...
Abbott’s ABSORB™ bioresorbable vascular scaffold honored with Wall Street Journal Technology Innovation Award
17 October 2011 | By Abbott
ABSORB™ bioresorbable vascular scaffold (BVS) has been recognized as the winner of the Medical Devices category...
Euticals and Intraco Chemicals sign an agreement for Euticals to acquire 40% of Pharmintraco
14 October 2011 | By INTRACO CHEMICALS LTD.
Euticals SpA, to acquire from Intraco Chemicals a 40% share of Pharmintraco GmbH...
Lundbeck establishes research centre in China
14 October 2011 | By H. Lundbeck A/S
For the first time ever, H. Lundbeck A/S has established its own research centre in China...
Risk Evaluation and Mitigation Strategy program for FENTORA and ACTIQ
13 October 2011 | By Cephalon Inc
Healthcare professionals who prescribe & dispense FENTORA® & ACTIQ® can enroll in the REMS program...
Amgen appoints Robert A. Bradway to the Company’s Board of Directors
13 October 2011 | By Amgen
Amgen announced that its Board of Directors has appointed Robert A. Bradway to the Company's Board...
